Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
Black Guy Walks Into Starbucks, Calls Them 'Racist,' Demands Free Coffee, Gets It Immediately
Laura Ingraham Interviews Comedian Who Requested Free Coffee From Starbucks As 'Reparations'
Syria Says U.S.-Led Strike Destroyed Pharmaceutical Research Institute Working On Cancer Drugs
UK Journalist Visits Syria, Local Doc Tells Him Douma Victims Suffered From Oxygen Starvation, Not 'Chem Attack'
Google Lawsuit: Senior Engineer Sought to 'Blacklist Alt-Right Websites' Like 'Breitbart,' Purge YouTube
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.